HK Stock MarketDetailed Quotes

01931 IVD MEDICAL

Watchlist
  • 1.640
  • +0.010+0.61%
Market Closed Nov 15 16:08 CST
2.67BMarket Cap9.32P/E (TTM)

IVD MEDICAL Key Stats

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Cash flow from operating activities
Earning before tax
----
19.57%339.33M
----
5.92%283.79M
----
15.51%267.94M
----
-21.88%231.96M
----
152.45%296.94M
Profit adjustment
Interest (income) - adjustment
----
-47.57%-2.91M
----
-12.17%-1.97M
----
16.33%-1.76M
----
50.63%-2.1M
----
-179.08%-4.26M
Attributable subsidiary (profit) loss
----
910.70%22.66M
----
66.47%-2.8M
----
-1,344.54%-8.34M
----
75.75%-577K
----
96.89%-2.38M
Impairment and provisions:
----
-86.38%3.28M
----
-3.55%24.09M
----
695.00%24.98M
----
-90.72%3.14M
----
1,342.01%33.84M
-Impairment of property, plant and equipment (reversal)
----
----
----
14.55%3.54M
----
--3.09M
----
----
----
----
-Impairmen of inventory (reversal)
----
343.87%4.24M
----
-90.07%955K
----
152.48%9.62M
----
3,102.52%3.81M
----
891.67%119K
-Impairment of trade receivables (reversal)
----
-135.56%-958K
----
236.75%2.69M
----
219.58%800K
----
-329.90%-669K
----
-87.54%291K
-Impairment of goodwill
----
----
----
----
----
----
----
----
----
--6.64M
-Other impairments and provisions
----
----
----
47.41%16.9M
----
--11.47M
----
----
----
--26.8M
Revaluation surplus:
----
80.10%20.63M
----
182.30%11.46M
----
-206.43%-13.92M
----
96.46%-4.54M
----
---128.14M
-Other fair value changes
----
80.10%20.63M
----
182.30%11.46M
----
-206.43%-13.92M
----
96.46%-4.54M
----
---128.14M
Asset sale loss (gain):
----
-2,920.00%-141K
----
-99.75%5K
----
120.58%1.98M
----
2,896.67%899K
----
900.00%30K
-Loss (gain) from sale of subsidiary company
----
----
----
----
----
--2.07M
----
----
----
----
-Loss (gain) on sale of property, machinery and equipment
----
-2,920.00%-141K
----
105.75%5K
----
-109.68%-87K
----
2,896.67%899K
----
900.00%30K
Depreciation and amortization:
----
6.43%37.56M
----
-9.06%35.29M
----
2.76%38.81M
----
-23.61%37.76M
----
178.58%49.44M
-Depreciation
----
14.10%23.97M
----
-16.24%21.01M
----
9.13%25.08M
----
--22.98M
----
----
-Amortization of intangible assets
----
----
----
-24.73%1.54M
----
--2.04M
----
----
----
1,028.49%14.22M
Financial expense
----
-31.20%21.04M
----
49.74%30.58M
----
-13.99%20.42M
----
205.05%23.75M
----
--7.78M
Special items
----
-90.56%1.83M
----
-52.81%19.41M
----
129.64%41.12M
----
-11.95%17.91M
----
--20.34M
Operating profit before the change of operating capital
----
10.86%443.28M
----
7.71%399.85M
----
20.46%371.24M
----
12.64%308.19M
----
358.57%273.6M
Change of operating capital
Inventory (increase) decrease
----
-1,225.47%-485.15M
----
125.93%43.11M
----
-267.87%-166.24M
----
-58.07%99.03M
----
6,693.63%236.18M
Accounts receivable (increase)decrease
----
327.50%36.7M
----
86.80%-16.13M
----
-203.10%-122.24M
----
57.94%-40.33M
----
-148.69%-95.89M
Accounts payable increase (decrease)
----
216.04%216.37M
----
-166.62%-186.46M
----
619.19%279.89M
----
-238.37%-53.91M
----
650.59%38.96M
prepayments (increase)decrease
----
99.44%197.4M
----
184.92%98.98M
----
-481.71%-116.55M
----
57.90%-20.04M
----
-13,976.68%-47.6M
Cash  from business operations
----
20.41%408.6M
----
37.89%339.34M
----
-15.99%246.1M
----
-27.71%292.94M
----
3,655.18%405.26M
Other taxs
----
-29.55%-116.17M
----
-8.05%-89.67M
----
32.22%-82.99M
----
-89.72%-122.45M
----
---64.54M
Special items of business
-97.15%3.74M
----
230.40%131.13M
----
-587.13%-100.55M
----
108.91%20.64M
----
-1,452.58%-231.59M
----
Net cash from operations
-97.15%3.74M
17.12%292.42M
230.40%131.13M
53.07%249.67M
-587.13%-100.55M
-4.33%163.11M
108.91%20.64M
-49.96%170.49M
-1,452.58%-231.59M
17,292.34%340.72M
Cash flow from investment activities
Interest received - investment
0.97%1.77M
47.57%2.91M
95.64%1.75M
12.17%1.97M
26.45%894K
-16.33%1.76M
-50.07%707K
-50.63%2.1M
-16.31%1.42M
179.08%4.26M
Loan receivable (increase) decrease
42.40%-2.49M
208.23%171K
60.95%-4.32M
-217.91%-158K
-8,671.43%-11.05M
210.74%134K
-168.11%-126K
-100.58%-121K
-99.12%185K
-32.25%20.69M
Sale of fixed assets
-70.41%877K
338.79%11.18M
648.48%2.96M
-69.10%2.55M
-94.97%396K
57.64%8.24M
--7.87M
36.81%5.23M
----
54,500.00%3.82M
Purchase of fixed assets
17.00%-14.26M
-18.15%-40.51M
-114.60%-17.18M
-35.88%-34.29M
37.05%-8.01M
1.53%-25.23M
-27.45%-12.72M
17.13%-25.63M
-17.56%-9.98M
-88.10%-30.92M
Sale of subsidiaries
----
----
----
----
----
--2.17M
----
----
----
----
Acquisition of subsidiaries
----
----
----
----
----
--9K
----
----
----
--252.38M
Recovery of cash from investments
----
13.43%13.81M
-60.24%4.84M
--12.18M
--12.18M
----
----
----
----
----
Cash on investment
-282.79%-41.69M
-183.22%-65.15M
-101.59%-10.89M
622.97%78.28M
56.24%-5.4M
91.59%-14.97M
91.60%-12.35M
-4,377.37%-177.9M
-1,124.15%-147.06M
--4.16M
Other items in the investment business
----
----
----
----
---3.1M
----
----
--309K
----
----
Net cash from investment operations
-144.37%-55.8M
-228.16%-77.59M
-62.02%-22.83M
317.10%60.54M
15.17%-14.09M
85.77%-27.88M
89.31%-16.61M
-177.05%-196M
-162.26%-155.43M
747.14%254.39M
Net cash before financing
-148.07%-52.06M
-30.74%214.84M
194.46%108.29M
129.40%310.21M
-2,945.54%-114.65M
630.10%135.22M
101.04%4.03M
-104.29%-25.51M
-245.07%-387.02M
1,760.39%595.1M
Cash flow from financing activities
New borrowing
87.87%1.18B
7.54%1.35B
-28.02%626.04M
16.88%1.26B
45.13%869.7M
6.49%1.07B
-26.91%599.25M
44.77%1.01B
485.62%819.87M
--696.8M
Refund
-51.34%-695.96M
-0.68%-1.36B
20.85%-459.87M
-27.62%-1.35B
-27.36%-581.03M
-14.47%-1.06B
-1.26%-456.23M
-35.08%-924.38M
-323.54%-450.53M
---684.32M
Issuing shares
----
----
----
--3.95M
--3.95M
----
----
----
----
--898.81M
Interest paid - financing
-8.29%-11.63M
31.20%-21.04M
9.84%-10.74M
-49.74%-30.58M
-33.46%-11.91M
13.99%-20.42M
28.11%-8.93M
-205.05%-23.75M
-340.09%-12.42M
---7.78M
Dividends paid - financing
3.00%-47.66M
-44.15%-76.35M
-12.04%-49.13M
-5.00%-52.96M
-8.53%-43.85M
41.00%-50.44M
---40.41M
62.67%-85.49M
----
---229.03M
Issuance expenses and redemption of securities expenses
----
----
----
----
----
----
----
54.76%-23.43M
---1.23M
---51.79M
Other items of the financing business
----
617.69%87.28M
---263K
-46.28%-16.86M
----
22.75%-11.53M
----
96.49%-14.92M
----
---424.54M
Net cash from financing operations
306.31%413.59M
89.83%-19.45M
-56.12%101.79M
-188.57%-191.29M
160.35%231.96M
-4.82%-66.29M
-74.57%89.1M
-131.92%-63.24M
1,567.32%350.37M
--198.14M
Effect of rate
-81.91%3.27M
-86.92%8.77M
-46.60%18.09M
392.64%67.08M
514.44%33.87M
31.60%-22.92M
-180.82%-8.17M
-1,580.82%-33.51M
21,414.89%10.11M
-44.38%2.26M
Net Cash
72.09%361.54M
64.30%195.39M
79.08%210.09M
72.51%118.92M
25.97%117.31M
177.68%68.94M
354.09%93.13M
-111.19%-88.75M
-112.73%-36.65M
2,379.82%793.24M
Begining period cash
20.00%1.22B
22.29%1.02B
22.29%1.02B
5.83%834.63M
5.83%834.63M
-13.42%788.61M
-13.42%788.61M
689.56%910.87M
689.56%910.87M
45.47%115.36M
Cash at the end
27.29%1.59B
20.00%1.22B
26.68%1.25B
22.29%1.02B
12.85%985.81M
5.83%834.63M
-1.22%873.57M
-13.42%788.61M
119.32%884.33M
689.56%910.87M
Cash balance analysis
Cash and bank balance
----
----
----
----
----
----
----
----
119.32%884.33M
----
Cash and cash equivalent balance
----
----
----
----
----
----
----
----
119.32%884.33M
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019
Cash flow from operating activities
Earning before tax ----19.57%339.33M----5.92%283.79M----15.51%267.94M-----21.88%231.96M----152.45%296.94M
Profit adjustment
Interest (income) - adjustment -----47.57%-2.91M-----12.17%-1.97M----16.33%-1.76M----50.63%-2.1M-----179.08%-4.26M
Attributable subsidiary (profit) loss ----910.70%22.66M----66.47%-2.8M-----1,344.54%-8.34M----75.75%-577K----96.89%-2.38M
Impairment and provisions: -----86.38%3.28M-----3.55%24.09M----695.00%24.98M-----90.72%3.14M----1,342.01%33.84M
-Impairment of property, plant and equipment (reversal) ------------14.55%3.54M------3.09M----------------
-Impairmen of inventory (reversal) ----343.87%4.24M-----90.07%955K----152.48%9.62M----3,102.52%3.81M----891.67%119K
-Impairment of trade receivables (reversal) -----135.56%-958K----236.75%2.69M----219.58%800K-----329.90%-669K-----87.54%291K
-Impairment of goodwill --------------------------------------6.64M
-Other impairments and provisions ------------47.41%16.9M------11.47M--------------26.8M
Revaluation surplus: ----80.10%20.63M----182.30%11.46M-----206.43%-13.92M----96.46%-4.54M-------128.14M
-Other fair value changes ----80.10%20.63M----182.30%11.46M-----206.43%-13.92M----96.46%-4.54M-------128.14M
Asset sale loss (gain): -----2,920.00%-141K-----99.75%5K----120.58%1.98M----2,896.67%899K----900.00%30K
-Loss (gain) from sale of subsidiary company ----------------------2.07M----------------
-Loss (gain) on sale of property, machinery and equipment -----2,920.00%-141K----105.75%5K-----109.68%-87K----2,896.67%899K----900.00%30K
Depreciation and amortization: ----6.43%37.56M-----9.06%35.29M----2.76%38.81M-----23.61%37.76M----178.58%49.44M
-Depreciation ----14.10%23.97M-----16.24%21.01M----9.13%25.08M------22.98M--------
-Amortization of intangible assets -------------24.73%1.54M------2.04M------------1,028.49%14.22M
Financial expense -----31.20%21.04M----49.74%30.58M-----13.99%20.42M----205.05%23.75M------7.78M
Special items -----90.56%1.83M-----52.81%19.41M----129.64%41.12M-----11.95%17.91M------20.34M
Operating profit before the change of operating capital ----10.86%443.28M----7.71%399.85M----20.46%371.24M----12.64%308.19M----358.57%273.6M
Change of operating capital
Inventory (increase) decrease -----1,225.47%-485.15M----125.93%43.11M-----267.87%-166.24M-----58.07%99.03M----6,693.63%236.18M
Accounts receivable (increase)decrease ----327.50%36.7M----86.80%-16.13M-----203.10%-122.24M----57.94%-40.33M-----148.69%-95.89M
Accounts payable increase (decrease) ----216.04%216.37M-----166.62%-186.46M----619.19%279.89M-----238.37%-53.91M----650.59%38.96M
prepayments (increase)decrease ----99.44%197.4M----184.92%98.98M-----481.71%-116.55M----57.90%-20.04M-----13,976.68%-47.6M
Cash  from business operations ----20.41%408.6M----37.89%339.34M-----15.99%246.1M-----27.71%292.94M----3,655.18%405.26M
Other taxs -----29.55%-116.17M-----8.05%-89.67M----32.22%-82.99M-----89.72%-122.45M-------64.54M
Special items of business -97.15%3.74M----230.40%131.13M-----587.13%-100.55M----108.91%20.64M-----1,452.58%-231.59M----
Net cash from operations -97.15%3.74M17.12%292.42M230.40%131.13M53.07%249.67M-587.13%-100.55M-4.33%163.11M108.91%20.64M-49.96%170.49M-1,452.58%-231.59M17,292.34%340.72M
Cash flow from investment activities
Interest received - investment 0.97%1.77M47.57%2.91M95.64%1.75M12.17%1.97M26.45%894K-16.33%1.76M-50.07%707K-50.63%2.1M-16.31%1.42M179.08%4.26M
Loan receivable (increase) decrease 42.40%-2.49M208.23%171K60.95%-4.32M-217.91%-158K-8,671.43%-11.05M210.74%134K-168.11%-126K-100.58%-121K-99.12%185K-32.25%20.69M
Sale of fixed assets -70.41%877K338.79%11.18M648.48%2.96M-69.10%2.55M-94.97%396K57.64%8.24M--7.87M36.81%5.23M----54,500.00%3.82M
Purchase of fixed assets 17.00%-14.26M-18.15%-40.51M-114.60%-17.18M-35.88%-34.29M37.05%-8.01M1.53%-25.23M-27.45%-12.72M17.13%-25.63M-17.56%-9.98M-88.10%-30.92M
Sale of subsidiaries ----------------------2.17M----------------
Acquisition of subsidiaries ----------------------9K--------------252.38M
Recovery of cash from investments ----13.43%13.81M-60.24%4.84M--12.18M--12.18M--------------------
Cash on investment -282.79%-41.69M-183.22%-65.15M-101.59%-10.89M622.97%78.28M56.24%-5.4M91.59%-14.97M91.60%-12.35M-4,377.37%-177.9M-1,124.15%-147.06M--4.16M
Other items in the investment business -------------------3.1M----------309K--------
Net cash from investment operations -144.37%-55.8M-228.16%-77.59M-62.02%-22.83M317.10%60.54M15.17%-14.09M85.77%-27.88M89.31%-16.61M-177.05%-196M-162.26%-155.43M747.14%254.39M
Net cash before financing -148.07%-52.06M-30.74%214.84M194.46%108.29M129.40%310.21M-2,945.54%-114.65M630.10%135.22M101.04%4.03M-104.29%-25.51M-245.07%-387.02M1,760.39%595.1M
Cash flow from financing activities
New borrowing 87.87%1.18B7.54%1.35B-28.02%626.04M16.88%1.26B45.13%869.7M6.49%1.07B-26.91%599.25M44.77%1.01B485.62%819.87M--696.8M
Refund -51.34%-695.96M-0.68%-1.36B20.85%-459.87M-27.62%-1.35B-27.36%-581.03M-14.47%-1.06B-1.26%-456.23M-35.08%-924.38M-323.54%-450.53M---684.32M
Issuing shares --------------3.95M--3.95M------------------898.81M
Interest paid - financing -8.29%-11.63M31.20%-21.04M9.84%-10.74M-49.74%-30.58M-33.46%-11.91M13.99%-20.42M28.11%-8.93M-205.05%-23.75M-340.09%-12.42M---7.78M
Dividends paid - financing 3.00%-47.66M-44.15%-76.35M-12.04%-49.13M-5.00%-52.96M-8.53%-43.85M41.00%-50.44M---40.41M62.67%-85.49M-------229.03M
Issuance expenses and redemption of securities expenses ----------------------------54.76%-23.43M---1.23M---51.79M
Other items of the financing business ----617.69%87.28M---263K-46.28%-16.86M----22.75%-11.53M----96.49%-14.92M-------424.54M
Net cash from financing operations 306.31%413.59M89.83%-19.45M-56.12%101.79M-188.57%-191.29M160.35%231.96M-4.82%-66.29M-74.57%89.1M-131.92%-63.24M1,567.32%350.37M--198.14M
Effect of rate -81.91%3.27M-86.92%8.77M-46.60%18.09M392.64%67.08M514.44%33.87M31.60%-22.92M-180.82%-8.17M-1,580.82%-33.51M21,414.89%10.11M-44.38%2.26M
Net Cash 72.09%361.54M64.30%195.39M79.08%210.09M72.51%118.92M25.97%117.31M177.68%68.94M354.09%93.13M-111.19%-88.75M-112.73%-36.65M2,379.82%793.24M
Begining period cash 20.00%1.22B22.29%1.02B22.29%1.02B5.83%834.63M5.83%834.63M-13.42%788.61M-13.42%788.61M689.56%910.87M689.56%910.87M45.47%115.36M
Cash at the end 27.29%1.59B20.00%1.22B26.68%1.25B22.29%1.02B12.85%985.81M5.83%834.63M-1.22%873.57M-13.42%788.61M119.32%884.33M689.56%910.87M
Cash balance analysis
Cash and bank balance --------------------------------119.32%884.33M----
Cash and cash equivalent balance --------------------------------119.32%884.33M----
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion------Unqualified Opinion--Unqualified Opinion
Auditor --Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data